A 68930

Known as: A-68930, A68930 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2017
02419902017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Dopamine activates D1-like and D2-like receptors (D1R and D2R). While D1R antagonists have ameliorated the severity of disease in… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Perinatal hypoxia is an important cause of brain injury amongst the newborn, such injury often resulting in an increased risk of… (More)
Is this relevant?
2007
2007
Bronx Waltzer (bv) mouse, which has been used as a model of hearing and vestibular dysfunction, shows remarkable repetitive… (More)
Is this relevant?
2005
2005
Structurally dissimilar dopamine D(1) receptor agonists were compared with dopamine in their ability to activate adenylate… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1998
1998
The role of drug efficacy in agonist-induced desensitization was studied in C-6 glioma cells transfected with the monkey dopamine… (More)
  • figure 2
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
1995
1995
The intrinsic activities of selected dopamine D1 receptor agonists were compared in three distinct molecular expression systems… (More)
Is this relevant?
1994
1994
We compared the effect of two selective dopamine D1 receptor agonists, SKF 38393 ((+/-)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3… (More)
Is this relevant?
1993
1993
Adenylyl cyclase activity was stimulated by dopamine to approximately 200% over basal activity in both squirrel monkey caudate… (More)
Is this relevant?
1993
1993
The effects of the dopamine D1 receptor full agonist, A68930, on sleep-wake patterns and grooming behaviour were studied in the… (More)
Is this relevant?
1991
1991
A68930, (1R,3S)-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman HCl, is a potent (EC50 = 2.5 nM), partial (intrinsic activity = 66… (More)
Is this relevant?